Melanotransferrin

Melanotransferrin

Melanotransferrin Molekülinformation

Molecule Name
Melanotransferrin
Molekülalias
Melanotransferrin,CD228,MFI2,MAP97,MELTF
Drug Development Progress
Anzahl der klinischen Arzneimittel2
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical
Target-Alias
Melanoma-associated antigen p97,CD228,Antigen P97 (Melanoma Associated) Identified By Monoclonal Antibodies 133.2 And 96.5,MAP97,Membrane-Bound Transferrin-Like Protein,MGC4856,MTF1,FLJ38863,CD228 Antigen,MTf,MFI2
Molekülhintergrund
Melanotransferrin (MTF), also known as CD228, P97, MELTF and MFI2, is a cell-surface glycoprotein found on melanoma cells. The protein shares sequence similarity and iron-binding properties with members of the transferrin superfamily. Involved in iron cellular uptake. Seems to be internalized and then recycled back to the cell membrane. Binds a single atom of iron per subunit. Could also bind zinc. MTF expression is low in normal tissues but high in tumor and embryonic tissues. In melanoma MTF is associated with tumor metastasis and angiogenesis and upregulated in lung cancer tissue and cell lines. In the brain MTF is expressed in capillary endothelium but also in the reactive microglia associated with senile plaques in Alzheimer's disease (AD).

Melanotransferrin Produktliste

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
BA-1302BA-1302; BA1302Phase 1 ClinicalShandong Boan Biotechnology Co Ltd
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Pancreatic Neoplasms; Solid tumours
Details
SGN-BB228SGN-BB228; PF-08046049; BB-228; PRS-346Phase 1 ClinicalPieris Pharmaceuticals
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Mesothelioma; Pancreatic Neoplasms; Skin Melanoma; Solid tumours
Details